T1	disease_or_phenotypic_feature 26 39	renal failure
T2	chemical 41 45	drug
T3	disease_or_phenotypic_feature 69 82	renal failure
T4	disease_or_phenotypic_feature 102 120	glomerulonephritis
T5	disease_or_phenotypic_feature 122 140	nephrotic syndrome
T6	disease_or_phenotypic_feature 167 187	potassium deficiency
T7	disease_or_phenotypic_feature 189 203	CHILD syndrome
T8	chemical 255 265	lovastatin
T9	chemical 270 281	cholesterol
T10	disease_or_phenotypic_feature 316 323	obesity
T11	chemical 371 380	estradiol
T12	disease_or_phenotypic_feature 423 430	obesity
T13	chemical 436 444	estrogen
T14	disease_or_phenotypic_feature 445 454	dependent
T15	disease_or_phenotypic_feature 455 462	cancers
T16	disease_or_phenotypic_feature 464 473	Potential
T17	chemical 491 501	biomarkers
T18	disease_or_phenotypic_feature 505 537	triple-negative breast carcinoma
T19	chemical 539 550	Cannabidiol
T20	disease_or_phenotypic_feature 583 591	seizures
T21	chemical 595 599	drug
T22	missed_disease_or_phenotypic_feature 595 625	drug resistant Dravet syndrome
T23	chemical 647 654	biology
T24	disease_or_phenotypic_feature 672 687	prostate cancer
T25	disease_or_phenotypic_feature 689 696	One-Pot
T26	chemical 722 731	Polyester
T27	chemical 820 828	Collagen
T28	chemical 833 844	fibronectin
T29	disease_or_phenotypic_feature 862 869	obesity
T30	disease_or_phenotypic_feature 874 887	breast cancer
T31	disease_or_phenotypic_feature 959 973	tumor-specific
T32	chemical 974 982	peptides
T33	chemical 1116 1122	sodium
T34	chemical 1123 1130	glucose
T35	chemical 1148 1158	inhibitors
T36	disease_or_phenotypic_feature 1179 1196	diabetes mellitus
T37	disease_or_phenotypic_feature 1210 1223	heart failure
T38	disease_or_phenotypic_feature 1266 1273	obesity
T39	chemical 1299 1306	mineral
T40	chemical 1307 1312	water
T41	disease_or_phenotypic_feature 1315 1322	Myeloma
T42	chemical 1350 1358	antigens
T43	chemical 1360 1367	Ghrelin
T44	disease_or_phenotypic_feature 1398 1412	heart diseases
T45	disease_or_phenotypic_feature 1414 1432	muscular dystrophy
T46	disease_or_phenotypic_feature 1448 1460	osteoporosis
T47	chemical 1468 1479	antagonists
T48	disease_or_phenotypic_feature 1501 1508	obesity
T49	disease_or_phenotypic_feature 1552 1561	infertile
T50	disease_or_phenotypic_feature 1562 1565	men
T51	chemical 1657 1669	antioxidants
T52	chemical 1730 1733	myc
T53	disease_or_phenotypic_feature 1814 1823	neoplasms
T54	chemical 1849 1861	biologically
T55	chemical 1897 1906	inhibitor
T56	chemical 1907 1916	sorafenib
T57	disease_or_phenotypic_feature 1963 1987	hepatocellular carcinoma
T58	disease_or_phenotypic_feature 2093 2106	renal failure
T59	chemical 2118 2130	fluvastatine
T60	disease_or_phenotypic_feature 2133 2147	Cardiomyopathy
T61	disease_or_phenotypic_feature 2152 2165	heart failure
T62	chemical 2179 2189	anesthetic
T63	chemical 2213 2219	sodium
T64	chemical 2220 2229	potassium
T65	disease_or_phenotypic_feature 2238 2245	obesity
T66	chemical 2247 2257	Paclitaxel
T67	chemical 2273 2277	drug
T68	disease_or_phenotypic_feature 2305 2326	peripheral neuropathy
T69	corrected_chemical 247 265	topical lovastatin
T70	corrected_chemical 270 288	cholesterol lotion
T71	missed_disease_or_phenotypic_feature 229 241	skin lesions
R1	treats Arg1:T69 Arg2:T7	
R2	treats Arg1:T70 Arg2:T7	
R3	treats Arg1:T69 Arg2:T71	
R4	treats Arg1:T70 Arg2:T71	
T72	corrected_disease_or_phenotypic_feature 572 591	convulsive seizures
R5	treats Arg1:T19 Arg2:T72	
R6	treats Arg1:T19 Arg2:T22	
T73	corrected_chemical 1116 1158	sodium-glucose co-transporter-2 inhibitors
T74	corrected_chemical 1280 1312	arsenic-containing mineral water
R7	treats Arg1:T74 Arg2:T38	
T75	corrected_chemical 1360 1376	Ghrelin mimetics
R8	treats Arg1:T75 Arg2:T44	
T76	missed_disease_or_phenotypic_feature 1433 1443	sarcopenia
R9	treats Arg1:T75 Arg2:T45	
R10	treats Arg1:T75 Arg2:T76	
R11	treats Arg1:T75 Arg2:T46	
T77	missed_disease_or_phenotypic_feature 1513 1531	insulin resistance
T78	corrected_chemical 1462 1479	GHS-R antagonists
R12	treats Arg1:T78 Arg2:T48	
R13	treats Arg1:T78 Arg2:T77	
T79	corrected_chemical 1885 1916	multikinase inhibitor sorafenib
T80	missed_disease_or_phenotypic_feature 1953 1958;1978 1987	renal carcinoma
R14	treats Arg1:T79 Arg2:T80	
R15	treats Arg1:T79 Arg2:T57	
T81	missed_disease_or_phenotypic_feature 2000 2018	tumor angiogenesis
T82	missed_disease_or_phenotypic_feature 2074 2088	rhabdomyolysis
T83	missed_chemical 2059 2065	Statin
R16	causes_or_contributes_to Arg1:T83 Arg2:T82	
R17	causes_or_contributes_to Arg1:T83 Arg2:T58	
R18	causes_or_contributes_to Arg1:T59 Arg2:T82	
R19	causes_or_contributes_to Arg1:T59 Arg2:T58	
R20	causes_or_contributes_to Arg1:T66 Arg2:T68	
R21	treats Arg1:T73 Arg2:T36	
T84	missed_chemical 1918 1925	NEXAVAR
R22	treats Arg1:T84 Arg2:T80	
R23	treats Arg1:T84 Arg2:T57	
R24	treats Arg1:T79 Arg2:T81	
R25	treats Arg1:T84 Arg2:T81	
T85	corrected_disease_or_phenotypic_feature 436 462	estrogen-dependent cancers
R26	causes_or_contributes_to Arg1:T11 Arg2:T85	
T86	corrected_chemical 2262 2277	anticancer drug
R27	causes_or_contributes_to Arg1:T86 Arg2:T68	
